Updates in Sunscreens and Other Photoprotection

Roger I. Ceilley, MD presented an update on advances in sunscreen technology, focusing on emerging strategies that go beyond ultraviolet (UV) blocking to address cumulative photodamage. Dr Ceilley reviewed data from a 12-week clinical study evaluating a tinted mineral-based SPF50 sunscreen formulated with photolyase, antioxidants, and peptides, highlighting the concept of combining photoprotection with active DNA repair support in daily practice.

The pilot study included 20 adults with Fitzpatrick skin types II–IV who applied the sunscreen daily for 12 weeks. Investigator assessments demonstrated progressive aesthetic improvement, with over half of participants showing improvement by Week 6 and more than 80% by Week 12 based on the Investigator Global Aesthetic Improvement Scale. Patient-reported outcomes mirrored these findings, with a majority reporting improved skin appearance over the study period. Statistically significant improvements were also observed in skin radiance, overall facial aesthetics, and skintone evenness, as measured by standardized grading scales.

Dr Ceilley emphasized that while endogenous DNA repair mechanisms exist, they may be insufficient to fully counteract ongoing UV exposure. The study supports the role of sunscreens that incorporate photolyase, antioxidants, and peptides as well-tolerated daily options that both protect against UV radiation and address visible signs of photoaging. These findings highlight an evolving approach to photoprotection that integrates prevention and repair within a single topical formulation.